Conference Preview
November 10, 2026
What ACH Will Be Watching at ObesityWeek 2026
Editorial Department, American Chamber of Health

The American Chamber of Health attends ObesityWeek 2026 as accredited media. Four questions will guide our coverage of the largest questions in obesity science this year.
When ObesityWeek 2026 opens on Saturday, November 14, at the Gaylord National Resort and Convention Center in National Harbor, Maryland, the American Chamber of Health will be in the room as accredited media. The annual scientific conference of The Obesity Society runs through Tuesday, November 17, and brings together researchers, clinicians, and policymakers working on obesity, a condition that now shapes the health of more than one billion people worldwide.
Our media department will follow hundreds of sessions across four days. Four questions will guide what we report back to our members and readers.
The science that will move practice
The center of gravity at this year's meeting is the new generation of obesity medicines, including the GLP-1 medicines that act on a hormone pathway involved in appetite and blood sugar. Sessions across the program take up how patients respond to these medicines, how they perform in everyday care outside of trials, and what patients themselves report about living on them. Phase 2 results for eloralintide, an investigational obesity medicine, will also be presented.
Two results stand out in advance. On Monday, November 16, researchers will present the STEP-YOUNG trial, a study of semaglutide for the treatment of childhood obesity. Evidence in children has lagged far behind the evidence in adults, and this trial speaks directly to that gap. The meeting will also hear the results of the LEAP trial, the first large study of the long term effectiveness of phentermine, one of the most prescribed obesity medicines in the United States and one of the oldest. For a medicine in such wide use, rigorous long term evidence has been thin, and clinicians will be listening closely.
Access, coverage, and the real world of care
Science only changes health when patients can reach it. ObesityWeek gives that question its own space, including a dedicated session on treatment access, coverage, and real world outcomes, and a Policy and Public Health track examining where evidence meets policy. ACH will be watching for what the field is learning about who gets treatment, who is left out, and what coverage decisions mean for both.
Artificial intelligence enters obesity care
A full session on Monday is devoted to precision medicine, artificial intelligence, and predictive modeling in obesity. The promise is considerable: tools that predict which treatment will work for which patient, and that help clinicians act earlier. Our coverage will hold a simple standard throughout. We will report what has been demonstrated, in how many patients, and what remains a promise.
Children, behavior, and the long view
The meeting opens with a two day course on comprehensive care for children living with obesity, and the program returns to young people throughout, alongside sessions on behavioral pathways and digital tools in weight management. The theme connects closely to the behavioral science initiative ACH announced this week with the International Institute of Behavioral Sciences. How behavior, environment, and medicine work together, rather than apart, is one of the questions this field is now taking most seriously.
What our coverage will bring you
Each morning of the conference, ACH News & Insights will publish a brief on what matters that day and what the previous day established. We will speak with researchers and clinicians presenting at the meeting, and after November 17 we will publish a closing analysis of what ObesityWeek 2026 changed in the field, and what it did not.
Members are welcome to send questions they would like our media department to pursue at the conference. Write to khalid@americanchamberofhealth.org.
The American Chamber of Health attends ObesityWeek 2026 as accredited media. This preview is based on the official conference program published by The Obesity Society, current as of October 29, 2026. Session times and titles may change; the conference program carries the final schedule.
